ARDT ARDENT HEALTH INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 15 analyst firms say about ARDENT HEALTH INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 15 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 6 reports on ARDT from 5 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 2 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Leerink Partners lowered its target from $15.00 (set 6 Mar 2026) to $14.00 on 18 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Kevin Fischbeck | Sell | 13 Nov 2025 | 10.00 USD |
| BMO Capital Markets | Sean Dodge | Hold | 22 Sep 2026 | 11.00 USD |
| Goldman Sachs | Scott Fidel | Hold | 25 Jun 2026 | 13.00 USD |
| Guggenheim | Jason Cassorla | Buy | 6 Aug 2026 | 14.00 USD |
| JPMorgan | Benjamin Rossi | Hold | 20 Jan 2026 | 11.00 USD |
| KeyBanc Capital Markets | Matthew Gillmor | Hold | 5 Aug 2026 | — |
| Leerink Partners | Whit Mayo | Buy | 18 Sep 2026 | 14.00 USD |
| Mizuho | Ann K Hynes | Buy | 21 Jul 2026 | 13.00 USD |
| Morgan Stanley | Craig Hettenbach | Hold | 14 Nov 2025 | 12.00 USD |
| RBC Capital Markets | Ben Hendrix | Buy | 10 Aug 2026 | 13.00 USD |
| Stephens | Raj Kumar | Buy | 1 Jul 2026 | 13.00 USD |
| Truist | David MacDonald | Buy | 6 Aug 2026 | 13.00 USD |
| UBS | A.J. Rice | Buy | 7 May 2026 | 13.50 USD |
| Weiss Ratings | Unnamed analyst | — | 6 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 7 Sep 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:02 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.